Trial intelligence / Profile preview

Aspirin versus hydroxyurea plus aspirin in intermediate-risk primary thrombocythemia, and aspirin versus observation in low-risk primary thrombocythemia

2004-000245-38Phase 3Completed

Sponsor

Assistance publique - Hôpitaux de Paris

Start

Apr 2007

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1